TATVA share price & delivery % — Tatva Chintan Pharma Chem

Filings & corporate actions

20 results filed

CSV

Next results · Q2 FY27

Expected 23 Oct 2026 – 5 Nov 2026

Estimate: filed 23–36 days after quarter end, last 5 times

Dividend

₹2.00 per share · last 11 Sept 2026

2026

11 SeptdividendDividend · ₹2.00 per share-3.0%
17 JulresultsResults · Q1 FY27 · consolidated and standalone+20.0%NSE
14 JulshareholdingShareholding · 30 Jun 2026+1.5%NSE
16 MayresultsResults · Q4 FY26 · consolidated and standalone-4.9%NSE
15 AprshareholdingShareholding · 31 Mar 2026+2.4%NSE
21 JanresultsResults · Q3 FY26 · consolidated and standalone-8.2%NSE
15 JanshareholdingShareholding · 31 Dec 2025+1.5%NSE

Reaction to results · all yearsrose on day 0 in 5 of 20 CSV

Quarter	Filed	Day 0	+5D	+20D	Rel vol
Q1 FY27	17 Jul 2026	+20.0%	+26.0%	+18.0%	58.0×
Q4 FY26	16 May 2026	-4.9%	-10.1%	-9.9%	3.1×
Q3 FY26	21 Jan 2026	-8.2%	-16.8%	-10.4%	11.4×
Q2 FY26	31 Oct 2025	-0.7%	+4.1%	+0.6%	2.1×
Q1 FY26	24 Jul 2025	+12.8%	+9.8%	+6.1%	22.0×
Q4 FY25	2 May 2025	+0.1%	+9.6%	+31.9%	2.5×
Q3 FY25	29 Jan 2025	-3.7%	-4.8%	-12.4%	2.3×
Q2 FY25	26 Oct 2024	-10.5%	-6.4%	-6.1%	6.1×
Q1 FY25	25 Jul 2024	-7.4%	-7.3%	-3.9%	6.4×
Q4 FY24	4 May 2024	-2.3%	-10.8%	-17.8%	1.3×
Q3 FY24	20 Jan 2024	-4.6%	-6.7%	-11.4%	3.3×
Q2 FY24	3 Nov 2023	-1.1%	+3.3%	+7.1%	2.3×
Q1 FY24	4 Aug 2023	+0.6%	+3.5%	+2.2%	3.3×
Q4 FY23	6 May 2023	-8.1%	-11.0%	-9.8%	3.5×
Q3 FY23	25 Jan 2023	-4.2%	-5.2%	-9.7%	4.2×
Q2 FY23	5 Nov 2022	-6.4%	-0.1%	-9.7%	15.1×
Q4 FY22	26 Apr 2022	-7.4%	-8.8%	-14.7%	8.9×
Q3 FY22	17 Jan 2022	-9.0%	-16.0%	-18.9%	6.6×
Q2 FY22	23 Oct 2021	+8.3%	+24.9%	+23.0%	5.7×
Q1 FY22	14 Aug 2021	-1.4%	-0.7%	+1.0%	—
Average		-1.9%	-1.2%	-2.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV

Revenue YoY+42.9%

Profit YoY+140.3%

Interest cost YoY+225.3%

Revenue QoQ+24.5%

Profit QoQ+54.8%

CAGR	2Y	3Y	4Y	5Y	6Y	7Y
Revenue	+20.2%	+7.3%	—	—	—	—
Profit	+40.4%	+4.4%	—	—	—	—

Key data

CSV

Open1,820.10

Day range1,794.30 – 1,900.00

52-week range981.50 – 1,900.00

From 52w high-1.2%

RSI (14)64.1

ATR (14)86.16

Volume1.33L

Avg volume (20D)78.2K

Rel volume1.70×

Volatility (1Y)51.8%

Turnover₹24.9Cr

SMA 50 / 2001,702.89 / 1,366.38

Delivery percentage

Latest · 6 Oct 202651.1%

20-day avg44.0%

1-year avg42.6%

Percentile (own history)54th

Range9.2–97.1%

Sessions1,282

Over the last 20 sessions TATVA settled 44.0% of its traded quantity, which is ordinary for an NSE equity. That is in line with its own one-year average of 42.6%. The latest session ranks higher than 54% of the 1,282 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

IndustrySpecialty Chemicals

PeersSOLARINDS TATACHEM FCL STEAMHOUSE HSCL SWANCORP

Performance returns

CSV

	1D	1W	1M	3M	6M	1Y
Price	+4.36%	+6.66%	+17.62%	+51.37%	+69.29%	+85.77%

Valuation

CSV

Market cap₹4,392 Cr

P/E (TTM)85.5

EPS (TTM)21.97

Shares outstanding2.34Cr

Listed29 Jul 2021

Ownership

CSV

Promoter72.02%

Promoter Δ QoQ0.00 pp

Public27.98%

FII3.93%

DII3.11%

Pledged0.00%

Quarterly results · consolidated

CSV

	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue (₹ Cr)	123.5	131.3	134.1	167.1
YoY chg	+47.9%	+52.9%	+24.4%	+42.9%
Net profit (₹ Cr)	9.9	15.2	10.3	16.0
YoY chg	—	+10889.1%	+902.0%	+140.3%
Net margin	8.0%	11.5%	7.7%	9.6%
EPS	4.24	6.49	4.41	6.83

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 72.02% · public 27.98%

2021-092026-06

Promoter
Public and others

Promoter: 72.02%
Public: 27.98%
Promoter change: 0.00 pp
Filed: 14 Jul 2026

FII: 3.93%
DII: 3.11%
Promoter pledged: 0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV

₹ crore, as filed

	Q2 FY24	Q3 FY24	Q4 FY24^A	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue from operations	96.7	84.2	98.3	105.5	83.5	85.9	107.9	116.9	123.5	131.3	134.1	167.1
Other income	0.8	1.2	4.5	1.2	0.4	0.0	0.7	1.2	1.0	1.7	(0.3)	2.8
Total income	97.4	85.4	102.8	106.6	83.9	85.9	108.6	118.0	124.5	133.1	133.8	169.8
Total expenses	86.2	80.2	89.1	99.8	84.9	86.2	106.6	108.9	110.9	115.4	117.2	147.4
└ Finance costs	3.0	0.4	0.2	0.3	0.2	0.4	0.4	0.4	0.5	0.5	1.4	2.1
└ Depreciation	6.8	6.6	6.2	6.7	6.8	6.9	7.3	9.0	9.1	9.1	9.8	10.6
Profit before tax	11.2	5.2	13.7	6.8	(1.0)	(0.2)	2.0	9.1	13.7	17.7	16.6	21.1
Tax expense	3.4	1.8	4.1	1.6	(0.4)	(0.4)	1.0	2.5	3.7	2.5	6.3	5.1
Net profit	7.8	3.5	9.6	5.2	(0.7)	0.1	1.0	6.7	9.9	15.2	10.3	16.0
EPS	3.43	1.48	4.11	2.23	-0.29	0.06	0.44	2.84	4.24	6.49	4.41	6.83
Net margin	8.05%	4.10%	9.78%	4.94%	-0.80%	0.16%	0.95%	5.69%	8.03%	11.55%	7.69%	9.57%
PBT margin	11.60%	6.23%	13.93%	6.46%	-1.22%	-0.27%	1.88%	7.79%	11.06%	13.45%	12.37%	12.64%
Tax rate	30.61%	34.12%	29.77%	23.50%	—	—	49.19%	26.92%	27.42%	14.12%	37.78%	24.30%

^A audited · ^R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 17 Jul 2026.

TATVA at a glance

TATVA closed at ₹1,877.4 on 6 Oct 2026, +4.36% on the day, +85.8% over one year, 1.2% below its 52-week high of ₹1,900.
Delivery was 51.1% of traded quantity on 6 Oct 2026, the 54th percentile of its own 1,282 sessions with a reading (20-session average 44.0%, 1-year average 42.6%).
Market capitalisation is ₹4,392 crore at a trailing P/E of 85.5 (trailing EPS ₹21.97).
Q1 FY27 results (consolidated, filed 17 Jul 2026): revenue ₹167 crore (+42.9% year on year), net profit ₹16 crore (+140.3%); the price moved +20.0% on the first session after.
Promoters held 72.02% at 30 Jun 2026, unchanged on the previous filing.
Q2 FY27 results are expected between 23 Oct 2026 and 5 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV

Macro sectorCommodities

Basic industrySpecialty Chemicals

ISININE0GK401011

SeriesEQ

Listed29 Jul 2021

History from29 Jul 2021

Sessions1,286

Turnover rank#920

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Chemicals & Petrochemicals

CSV

All Chemicals & Petrochemicals stocks on the NSE All Chemicals stocks on the NSE